 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Daniel Matlock and Robert Page.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.346 |
|
|
|
-
Allen LA, Venechuk G, McIlvennan CK, Page RL, Knoepke CE, Helmkamp LJ, Khazanie P, Peterson PN, Pierce K, Harger G, Thompson JS, Dow TJ, Richards L, Huang J, Strader JR, Trinkley KE, Kao DP, Magid DJ, Buttrick PM, Matlock DD. An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF Trial. Circulation. 2021 02 02; 143(5):427-437.
Score: 0.182
-
Lowe EF, Gerasta D, Balser M, Page RL, Tsai E, Biermann HD, Mitchell A, Chan D, Matlock DD, Dickert NW, Sloan CE, Allen LA. Contributors and Solutions to High?Out-of-Pocket Costs for Heart?Failure Medications: A State-of-the-Art Review. J Am Coll Cardiol. 2025 Feb 04; 85(4):365-377.
Score: 0.061
-
Lipsey J, Allen LA, Page RL, Helmkamp LJ, Venechuk G, Trinkley KE, Matlock DD, McIlvennan CK. Association of multimorbidity with guideline-directed medical therapy intensification in heart failure: Findings from the EPIC-HF trial. Heliyon. 2024 Jul 15; 10(13):e34178.
Score: 0.058
-
Venechuk GE, Khazanie P, Page RL, Knoepke CE, Helmkamp LJ, Peterson PN, Pierce K, Thompson JS, Huang J, Strader JR, Dow TJ, Richards L, Trinkley KE, Kao DP, McIlvennan CK, Magid DJ, Buttrick PM, Matlock DD, Allen LA. An Electronically delivered, Patient-activation tool for Intensification of medications for Chronic Heart Failure with reduced ejection fraction: Rationale and design of the EPIC-HF trial. Am Heart J. 2020 11; 229:144-155.
Score: 0.045
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|